LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Top Cited Papers
- 1 February 2018
- journal article
- research article
- Published by Elsevier BV in Cell Metabolism
- Vol. 27 (2), 461-469.e6
- https://doi.org/10.1016/j.cmet.2017.10.016
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor SignalingJournal of Biological Chemistry, 2017
- Peptide therapeutics: current status and future directionsDrug Discovery Today, 2015
- International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric LigandsPharmacological Reviews, 2014
- The Growth Hormone Secretagogue ReceptorPublished by Elsevier BV ,2007
- Fuel Metabolism in StarvationAnnual Review of Nutrition, 2006
- The Distribution and Mechanism of Action of Ghrelin in the CNS Demonstrates a Novel Hypothalamic Circuit Regulating Energy HomeostasisNeuron, 2003
- Genetic approaches to studying energy balance: perception and integrationNature Reviews Genetics, 2002
- Elevated plasma ghrelin levels in Prader–Willi syndromeNature Medicine, 2002
- Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass SurgeryNew England Journal of Medicine, 2002
- A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in HumansDiabetes, 2001